Halozyme Therapeutics, Inc. (HALO) Earnings
NASDAQ·Healthcare·Biotechnology
$63.70
-1.23%
Mkt Cap $8.10B
Next Earnings
In 6 daysTue, May 5, 2026
EPS Estimate
$1.54
4 analysts
Revenue Estimate
$358.56M
Last quarter: missed by -111.16% on EPS, +3.69% on revenue.
EPS — Estimate vs Actual
Mkt Cap
$8.10B
P/E
25.86
Fwd P/E
7.47
P/S
5.80
Rev TTM
—
EPS TTM
$2.49